| dc.contributor.advisor | 吳文傑 | zh_TW |
| dc.contributor.advisor | Wu, Jack | en_US |
| dc.contributor.author (Authors) | 鍾雯華 | zh_TW |
| dc.contributor.author (Authors) | Chung, Wendy | en_US |
| dc.creator (作者) | 鍾雯華 | zh_TW |
| dc.creator (作者) | Chung, Wendy | en_US |
| dc.date (日期) | 2010 | en_US |
| dc.date.accessioned | 29-Sep-2011 18:20:15 (UTC+8) | - |
| dc.date.available | 29-Sep-2011 18:20:15 (UTC+8) | - |
| dc.date.issued (上傳時間) | 29-Sep-2011 18:20:15 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0097933002 | en_US |
| dc.identifier.uri (URI) | http://nccur.lib.nccu.edu.tw/handle/140.119/50958 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 國際經營管理英語碩士學位學程(IMBA) | zh_TW |
| dc.description (描述) | 97933002 | zh_TW |
| dc.description (描述) | 99 | zh_TW |
| dc.description.abstract (摘要) | The case study provides an analysis of the business strategy and advantages of Company M, a German-based pharmaceutical company and current leader in Taiwan’s reproductive health treatment market. This study reviews how Company M’s follicle-stimulating hormone (FSH) Product G has been able to maintain a leading position in the market despite declining birth rate in Taiwan; the important role of (FSH), an essential hormone in the treatment of infertility; and the study of Company M, the leading pharmaceutical company in the treatment of infertility in the world and in Taiwan. Two major strategies are to establish superior Key Account Management and education programs to further strengthen market leadership position of Product G and further educate public about correct reproductive health treatment. A longer-term strategy is to increase the total Taiwan fertility market through support of Taiwan fertility society and industry to lobby for government funding for IVF subsidy | en_US |
| dc.description.abstract (摘要) | CH1 Introduction 1 CH2 M Company Profile 2 2.1 Company Background 2 2.2 Business Scope 5 2.3 M Company in Taiwan 8 CH3 Reproductive Health treatment overview 14 3.1 Fertility overview and causes of infertility 14 3.2 Reproductive health treatments 15 Follicle-stimulating hormone (FSH) – Product G 22 CH4 Market Overview 24 4.1 Taiwan reproductive health market overview 24 4.2 Key competitors in the market 27 CH5 Business strategy of M Company Fertility business 31 5.1 Global strategy 31 5.2 Local strategy 34 5.2.1 MS Taiwan Fertility business strategy 35 5.2.2 Product G Sales in Taiwan 36 5.2.3 Product positioning 38 5.3 Recent innovative local projects and practices 40 5.3.1 Fertility society and Fertility Hotline sponsorship 40 5.3.2 Establishing leadership through active industry participation 41 5.4 Competitive Advantage 42 CH6 Conclusion and Recommendation 45 Reference 49 | - |
| dc.description.tableofcontents | CH1 Introduction 1 CH2 M Company Profile 2 2.1 Company Background 2 2.2 Business Scope 5 2.3 M Company in Taiwan 8 CH3 Reproductive Health treatment overview 14 3.1 Fertility overview and causes of infertility 14 3.2 Reproductive health treatments 15 Follicle-stimulating hormone (FSH) – Product G 22 CH4 Market Overview 24 4.1 Taiwan reproductive health market overview 24 4.2 Key competitors in the market 27 CH5 Business strategy of M Company Fertility business 31 5.1 Global strategy 31 5.2 Local strategy 34 5.2.1 MS Taiwan Fertility business strategy 35 5.2.2 Product G Sales in Taiwan 36 5.2.3 Product positioning 38 5.3 Recent innovative local projects and practices 40 5.3.1 Fertility society and Fertility Hotline sponsorship 40 5.3.2 Establishing leadership through active industry participation 41 5.4 Competitive Advantage 42 CH6 Conclusion and Recommendation 45 Reference 49 | zh_TW |
| dc.language.iso | en_US | - |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0097933002 | en_US |
| dc.subject (關鍵詞) | 生殖醫學 | zh_TW |
| dc.subject (關鍵詞) | FSH | en_US |
| dc.title (題名) | 生殖醫學藥物產品G之業務策略分析─M企業在台灣個案分析 | zh_TW |
| dc.title (題名) | Business strategy analysis of FSH Product G - case study of M company in Taiwan | en_US |
| dc.type (資料類型) | thesis | en |
| dc.relation.reference (參考文獻) | 【1】 The Merck Group, www.merck.de | zh_TW |
| dc.relation.reference (參考文獻) | 【2】 Merck Serono S.A., www.merckserono.com | zh_TW |
| dc.relation.reference (參考文獻) | 【3】 Fertility, www.fertility.com | zh_TW |
| dc.relation.reference (參考文獻) | 【4】 Wikipedia, http://en.wikipedia.org | zh_TW |
| dc.relation.reference (參考文獻) | 【5】 Merck & Co., www.merck.com | zh_TW |
| dc.relation.reference (參考文獻) | 【6】 Ferring Pharmaceuticals, www.ferring.com | zh_TW |
| dc.relation.reference (參考文獻) | 【7】 Institut Biochimique SA, www.ibsa.com | zh_TW |
| dc.relation.reference (參考文獻) | 【8】 Department of Household Registration Affairs, MOI., www.ris.gov.tw | zh_TW |
| dc.relation.reference (參考文獻) | 【9】 Index Mundi, http://www.indexmundi.com | zh_TW |
| dc.relation.reference (參考文獻) | 【10】 Drugs.com, www.drugs.com/ | zh_TW |
